Literature DB >> 33711410

Impact of dose to lung outside the planning target volume on distant metastasis or progression after SBRT for early-stage non-small cell lung cancer.

Ryan T Hughes1, Cole R Steber2, Travis J Jacobson2, Michael K Farris2.   

Abstract

Mean dose (EQD2) to 3-cm shell of lung surrounding the PTV was evaluated for association with distant metastasis and PFS after SBRT for stage I NSCLC. Dose was uniformly above previously determined threshold and metastasis was uncommon. An association between outcomes and mean EQD2 could not be confirmed or refuted.
Copyright © 2021 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Lung cancer; Metastasis; Non-small cell lung cancer; Stereotactic body radiotherapy

Mesh：

Year:  2021        PMID： 33711410      PMCID： PMC8292923          DOI： 10.1016/j.radonc.2021.03.004

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN： 0167-8140            Impact factor:   6.280


  25 in total

1.  A dose-volume analysis of radiation pneumonitis in non-small cell lung cancer patients treated with stereotactic body radiation therapy.

Authors:  R Bryan Barriger; Jeffrey A Forquer; Jeffrey G Brabham; David L Andolino; Ronald H Shapiro; Mark A Henderson; Peter A S Johnstone; Achilles J Fakiris
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-10-29       Impact factor: 7.038

2.  Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support.

Authors:  Paul A Harris; Robert Taylor; Robert Thielke; Jonathon Payne; Nathaniel Gonzalez; Jose G Conde
Journal:  J Biomed Inform       Date:  2008-09-30       Impact factor: 6.317

3.  Dose-response relationship with clinical outcome for lung stereotactic body radiotherapy (SBRT) delivered via online image guidance.

Authors:  Larry Kestin; Inga Grills; Matthias Guckenberger; Jose Belderbos; Andrew J Hope; Maria Werner-Wasik; Jan-Jakob Sonke; Jean-Pierre Bissonnette; Ying Xiao; Di Yan
Journal:  Radiother Oncol       Date:  2014-03-11       Impact factor: 6.280

Review 4.  Simple Factors Associated With Radiation-Induced Lung Toxicity After Stereotactic Body Radiation Therapy of the Thorax: A Pooled Analysis of 88 Studies.

Authors:  Jing Zhao; Ellen D Yorke; Ling Li; Brian D Kavanagh; X Allen Li; Shiva Das; Moyed Miften; Andreas Rimner; Jeffrey Campbell; Jinyu Xue; Andrew Jackson; Jimm Grimm; Michael T Milano; Feng-Ming Spring Kong
Journal:  Int J Radiat Oncol Biol Phys       Date:  2016-03-25       Impact factor: 7.038

5.  Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Authors:  P E Postmus; K M Kerr; M Oudkerk; S Senan; D A Waller; J Vansteenkiste; C Escriu; S Peters
Journal:  Ann Oncol       Date:  2017-07-01       Impact factor: 32.976

6.  Comparing local control and distant metastasis in NSCLC patients between CyberKnife and conventional SBRT.

Authors:  André Diamant; Veng Jean Heng; Avishek Chatterjee; Sergio Faria; Houda Bahig; Edith Filion; Robert Doucet; Farzin Khosrow-Khavar; Issam El Naqa; Jan Seuntjens
Journal:  Radiother Oncol       Date:  2020-02-07       Impact factor: 6.280

7.  Outcomes of stereotactic ablative radiotherapy for centrally located early-stage lung cancer.

Authors:  Cornelis J A Haasbeek; Frank J Lagerwaard; Ben J Slotman; Suresh Senan
Journal:  J Thorac Oncol       Date:  2011-12       Impact factor: 15.609

8.  Microscopic disease extensions as a risk factor for loco-regional recurrence of NSCLC after SBRT.

Authors:  Francisco J Salguero; Jose S A Belderbos; Maddalena M G Rossi; Johannes L G Blaauwgeers; Joep Stroom; Jan-Jakob Sonke
Journal:  Radiother Oncol       Date:  2013-10-04       Impact factor: 6.280

9.  Comprehensive analysis of pulmonary function Test (PFT) changes after stereotactic body radiotherapy (SBRT) for stage I lung cancer in medically inoperable patients.

Authors:  Kevin L Stephans; Toufik Djemil; Chandana A Reddy; Stephen M Gajdos; Mathew Kolar; Michael Machuzak; Peter Mazzone; Gregory M M Videtic
Journal:  J Thorac Oncol       Date:  2009-07       Impact factor: 15.609

10.  Management of mediastinal relapse after treatment with stereotactic body radiotherapy or accelerated hypofractionated radiotherapy for stage I/II non-small-cell lung cancer.

Authors:  Jeremy M Kilburn; Scott C Lester; John T Lucas; Michael H Soike; A William Blackstock; William T Kearns; William H Hinson; Antonius A Miller; William J Petty; Michael T Munley; James J Urbanic
Journal:  J Thorac Oncol       Date:  2014-04       Impact factor: 15.609
View more
  1 in total

Review 1.  Value of carbon-ion radiotherapy for early stage non-small cell lung cancer.

Authors:  Hanguang Ruan; Juan Xiong
Journal:  Clin Transl Radiat Oncol       Date:  2022-06-14
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.